Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 248

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Mechanistic Basis of Enzyme-Targeted Drugs

Robertson, James G. · 2005 · Biochemistry

Abstract

Enzymes offer unique opportunities for drug design that are not available to cell surface receptors, nuclear hormone receptors, ion channels, transporters, and DNA. Here, we review the variety of inhibition mechanisms for enzyme-targeted drugs, and establish an enzyme target database for drugs currently marketed in the United States. From an analysis of the FDA Orange Book, there are 317 marketed drugs that work by inhibiting an enzyme. These drugs inhibit 71 enzymes, including 48 human, 13 bacterial, five viral, four fungal, and one protozoal enzyme. Among the 317 drugs, 65% either undergo reactive chemistry in the active site of the target enzyme or contain a structural motif related to the substrate. Among the 71 enzyme targets, 25 are irreversibly inhibited by drugs, and 19 of the 25 irreversibly inhibited enzymes are covalently modified by the drug. In two additional cases, the drug forms a covalent complex with the substrate, and in three more cases, the drug traps a covalent enzyme-substrate intermediate. Four of the 71 enzymes are inhibited by transition-state analogues. Moreover, advanced methods for determining transition-state structure now offer the opportunity for direct drug design without resorting to expensive random testing campaigns. A full appreciation of enzyme mechanisms sets enzymes apart as a specialized class of targets for highly directed drug design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/bi050247e

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 158

  1. International Human Genome Sequence Consortium, 2004, Nature 431, 931−945.
  2. Drews J., 2000, Science 287
  3. Center for Drug Evaluation and Research, 2002, New Molecular Entities (NMEs) Reports
  4. Oneil M. J., 2001, The Merck Index
  5. Hardman J. G., 2001, Goodman & Gilman's The Pharmacological Basis of Therapeutics
  6. DiPiro J. T., 2002, Pharmacotherapy: A Pathophysiologic Approach
  7. McEvoy G. K., 2002, AHFS Drug Information
  8. Center for Drug Evaluation and Research, 2003, Electronic Orange Book
  9. Tipper D. J., 1965, Proc. Natl. Acad. Sci. U.S.A. 54
  10. Istvan E. S., 2001, Science 292, 1160−1164.
  11. Lienhard G. E., 1973, Science 180, 149−154.
  12. Wolfenden R., 1976, Rev. Biophys. Bioeng., 5, 10.1146/annurev.bb.05.060176.001415 · DOI · Paper page
  13. Radzicka A., 1995, Methods Enzymol. 249, 284−312.
  14. Agarwal R. P., 1977, Biochem. Pharmacol. 26, 359−367.
  15. Cushman D. W., 1987, J. Cardiovasc. Pharmacol., 10, 10.1097/00005344-198706107-00004 · DOI
  16. Byers L. D., 1973, Biochemistry 12
  17. Roberts N. A., 1990, Science 248, 358−361.
  18. Chong A. K., 1992, Eur. J. Biochem., 207, 10.1111/j.1432-1033.1992.tb17055.x · DOI · Paper page
  19. von Iztstein M., 1993, Nature 363, 418−423.
  20. Schramm V. L., 2005, Arch. Biochem. Biophys., 433, 26, 10.1016/j.abb.2004.08.035 · DOI
  21. Evans G. B., 2004, J. Med. Chem., 47, 10.1021/jm0306475 · doi:10.1021/jm0306475
  22. Lu W. P., 2001, J. Biol. Chem., 276
  23. Goffin C., 1998, Microbiol. Mol. Biol. Rev., 62, 10.1128/MMBR.62.4.1079-1093.1998 · DOI · Paper page
  24. Christensen H., 1990, Biochem. J., 266
  25. Kahan F. M., 1974, Ann. N.Y. Acad. Sci. 235, 364−386.
  26. Thomas A. M., 2004, Eur. J. Biochem., 271, 10.1111/j.1432-1033.2004.04196.x · doi:10.1111/j.1432-1033.2004.04196.x
  27. Hemler M., 1976, J. Biol. Chem., 251, 10.1016/S0021-9258(17)33098-3 · DOI · Paper page
  28. Van Der Ouderaa F. J., 1980, Eur. J. Biochem., 109, 8
  29. Siiteri P. K., 1975, J. Steroid Biochem., 6, 10.1016/0022-4731(75)90149-1 · DOI · Paper page
  30. Brueggemeier R. W., 2001, Am. J. Ther., 8, 10.1097/00045391-200109000-00007 · DOI
  31. Finberg J. P., 1983, Neuropharmacology 22, 441−446.
  32. Fowler C. J., 1982, Biochem. Pharmacol. 31, 3555−3561.
  33. Santi D. V., 1974, Biochemistry 13, 471−481.
  34. Poulin R., 1992, J. Biol. Chem., 267, 10.1016/S0021-9258(18)48472-4 · DOI · Paper page
  35. Grishin N. V., 1999, Biochemistry 38, 15174−15184.
  36. Wang E., 1978, Biochemistry 17, 1313−1321.
  37. Fenn T. D., 2003, Biochemistry 42, 5775−5783.
  38. Richardson P., 1998, Drugs 56, 307−335.
  39. Hadvary P., 1991, J. Biol. Chem., 266, 10.1016/S0021-9258(18)52203-1 · DOI · Paper page
  40. Winkler F. K., 1990, Nature 343, 771−774.
  41. Baker C. H., 1991, J. Med. Chem., 34, 10.1021/jm00110a019 · DOI · Paper page
  42. Nagasaka A., 1976, J. Clin. Endocrinol. Metab., 43, 10.1210/jcem-43-1-152 · doi:10.1210/jcem-43-1-152
  43. Engler H., 1983, Endocrinology, 112, 95, 10.1210/endo-112-1-86 · DOI
  44. Kohrle J., 1999, Mol. Cell. Endocrinol. 151, 103−119.
  45. Berry M. J., 1991, J. Biol. Chem., 266
  46. Yamada T., 1981, J. Endocrinol. Invest., 4, 10.1007/BF03348299 · DOI
  47. Kitson T. M., 1975, Biochem. J., 151, 10.1042/bj1510407 · DOI
  48. Tomlinson A. J., 1997, Biochem. Pharmacol. 54, 1253−1260.
  49. Shen M. L., 2001, Biochem. Pharmacol. 61, 537−545.
  50. Jin L., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
  51. Hoylaerts M., 1984, J. Biol. Chem., 259, 10.1016/S0021-9258(18)91066-5 · DOI
  52. Rezaie A. R., 2000, Biochemistry 39, 12083−12090.
  53. Braun P. J., 1988, Biochemistry 27, 6517−6522.
  54. Holme E., 1998, J. Inherited Metab. Dis., 21
  55. Kavana M., 2003, Biochemistry 42, 10238−10245.
  56. Fasco M. J., 1983, Biochemistry 22, 5655−5660.
  57. Fasco M. J., 1982, J. Biol. Chem., 257
  58. Hughes J., 1980, Biochem. J., 191, 10.1042/bj1910209 · DOI
  59. Pope A. J., 1998, J. Biol. Chem., 273
  60. Furman P. A., 1984, J. Biol. Chem., 259, 10.1016/S0021-9258(17)42739-6 · DOI · Paper page
  61. Bull H. G., 1996, J. Am. Chem. Soc., 118
  62. Rozwarski D. A., 1998, Science, 279, 102, 10.1126/science.279.5347.98 · DOI · Paper page
  63. Quemard A., 1996, J. Am. Chem. Soc., 118, 10.1021/ja950998b · DOI
  64. Harrison R., 2002, Structure and function of xanthine oxidoreductase: Where are we now? Free Radical Biol. Med. 33, 774−797
  65. Silverman R. B., 1992, The Organic Chemistry of Drug Design and Drug Action
  66. Massey V., 1970, J. Biol. Chem., 245
  67. Spector T., 1970, J. Biol. Chem., 245, 10.1016/S0021-9258(18)62820-0 · DOI
  68. Sintchak M. D., 2000, Immunopharmacology 47, 163−184.
  69. Fleming M. A., 1996, Biochemistry 35, 6990−6997.
  70. Drlica K., 1997, Microbiol. Mol. Biol. Rev., 61
  71. Higgins P. G., 2003, Curr. Drug Targets 4, 181−190.
  72. Osheroff N., 1989, Pharmacol. Ther. 41, 223−241.
  73. Redinbo M. R., 1998, Science 279, 1504−1513.
  74. Fan Y., 1998, J. Med. Chem., 41
  75. Sander M., 1983, J. Biol. Chem., 258
  76. Wigley D. B., 1996, Structure 4, 117−120.
  77. Yang W., 2003, Med. Res. Rev., 23
  78. Kaplan A. P., 1991, Biochemistry 30, 8165−8170.
  79. Adams J., 2002, Oncologist, 7, 16, 10.1634/theoncologist.7-1-9 · DOI · Paper page
  80. Palombella V. J., 1998, Proc. Natl. Acad. Sci. U.S.A. 95
  81. Spence R. A., 1995, Science 267, 988−993.
  82. Grimsby J., 2003, Science 301, 370−373.
  83. Glaser B., 1998, N. Engl. J. Med., 338
  84. Christesen H. B., 2002, Diabetes 51, 1240−1246.
  85. Lee H., 2003, Biochemistry 42, 14711−14719.
  86. Feldmesser M., 2000, J. Infect. Dis., 182, 10.1086/317614 · DOI
  87. Coirini H., 2003, J. Neurochem., 84, 10.1046/j.1471-4159.2003.01512.x · DOI
  88. Corbin J. D., 1999, J. Biol. Chem., 274, 10.1074/jbc.274.20.13729 · DOI · Paper page
  89. Londesborough J., 1977, Biochem. J., 163, 10.1042/bj1630467 · doi:10.1042/bj1630467
  90. Hall M. G., 2001, Br. J. Clin. Pharmacol., 52
  91. Andriole G., 2004, J. Urol., 172
  92. Jann M. W., 2002, Clin. Pharmacokinet. 41, 719−739.
  93. Merkler D. J., 1990, Biochemistry 29, 8358−8364.
  94. Mustata G. I., 2003, Biopolymers 70, 186−200.
  95. Plapp B. V., 1984, Arch. Biochem. Biophys., 230, 38, 10.1016/0003-9861(84)90083-3 · doi:10.1016/0003-9861(84)90083-3
  96. Lipsky J. J., 2001, Chem.-Biol. Interact. 130−132, 93−102.
  97. Ferey-Roux G., 1998, Biochim. Biophys. Acta, 1388, 20, 10.1016/S0167-4838(98)00147-2 · DOI
  98. Sels J. P., 1999, Expert Opin. Pharmacother. 1, 149−156.
  99. Mallinger A. G., 1991, Psychopharmacol. Bull. 27, 493−502.
  100. Belanger A. E., 1996, Proc. Natl. Acad. Sci. U.S.A. 93
  101. Bell R. L., 1992, Int. J. Immunopharmacol., 14
  102. Burkhard P., 2001, Nat. Struct. Biol. 8, 963−967.
  103. Livermore D. M., 1993, J. Antimicrob. Chemother. 31 (Suppl. A), 9−21.
  104. Wells J. W., 1975, J. Biol. Chem., 250, 10.1016/S0021-9258(19)41546-9 · DOI
  105. Kurth M. C., 1998, Neurology, 50, S14, 10.1212/WNL.50.5_Suppl_5.S3 · doi:10.1212/wnl.50.5_suppl_5.s3
  106. Platt F. M., 1994, J. Biol. Chem., 269
  107. Fan C., 1997, Biochemistry 36, 2531−2538.
  108. Williams J. W., 1979, Biochemistry 18, 2567−2573.
  109. McLean J. E., 2001, Biochemistry 40, 2194−2200.
  110. Baca A. M., 2000, J. Mol. Biol., 302
  111. Arun B., 2001, Expert Opin. Pharmacother. 2, 491−505.
  112. Anderson V. E., 2001, Curr. Pharm. Des. 7, 337−353.
  113. Villarreal E. C., 2001, Prog. Drug Res. Spec. No., 185−228.
  114. Campbell E. A., 2001, Cell 104, 901−912.
  115. Stone K. J., 1971, Proc. Natl. Acad. Sci. U.S.A. 68
  116. Vilcheze C., 2000, J. Bacteriol., 182, 10.1128/JB.182.14.4059-4067.2000 · DOI · Paper page
  117. Kiefel M. J., 1999, Prog. Med. Chem., 36, 28
  118. Keam S. J., 2002, Drugs 62, 1673−1685
  119. Bergstrom J. D., 2000, Arch. Biochem. Biophys. 373, 231−241.
  120. Zimhony O., 2000, 6, 1043−1047.
  121. Samulitis B. K., 1987, Drugs Exp. Clin. Res. 13, 517−524.
  122. Phiel C. J., 2001, J. Biol. Chem., 276
  123. Rodriguez-Barrios F., 2004, Chem. 4, 991−1007.
  124. Sachs G., 1995, Rev. Pharmacol. Toxicol., 35
  125. Istvan E. S., 2002, Am. Heart J., 144, 10.1067/mhj.2002.130300 · DOI
  126. Sintchak M. D., 1996, Cell 85, 921−930.
  127. Engler H., 1982, Biochem. Pharmacol. 31, 3801−3806.
  128. Brown M. J., 2000, Biochemistry 39, 6003−6011.
  129. Campbell B. J., 1984, J. Biol. Chem., 259
  130. Bacchi C. J., 1980, Science 210, 332−334.
  131. Fyfe J. A., 1973, J. Biol. Chem., 248
  132. Cushman D. W., 1982, Am. J. Cardiol., 49, 10.1016/0002-9149(82)90348-4 · DOI
  133. Mendelsohn L. G., 1996, Invest. New Drugs 14, 287−294.
  134. Scott C. F., 1987, Blood 69, 1431−1436.
  135. Markus G., 1978, J. Biol. Chem., 253
  136. Gierse J. K., 1996, J. Biol. Chem., 271, 10.1074/jbc.271.26.15810 · DOI · Paper page
  137. Adams J., 1999, Cancer Res. 59, 2615−2622.
  138. Schindler T., 2000, Science 289
  139. Silva D. J., 1998, Biochemistry 37, 5528−5535.
  140. Maag D., 2001, J. Biol. Chem., 276, 10.1074/jbc.C100349200 · DOI · Paper page
  141. Sluis-Cremer N., 2004, Curr. HIV Res. 2, 323−332.
  142. Lee W., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
  143. Smith T. W., 1989, Therapie 44, 431−435.
  144. Favre B., 1997, Arch. Biochem. Biophys. 340, 265−269.
  145. Yoshida Y., 1987, Biochem. Pharmacol. 36, 229−235.
  146. Lembcke B., 1985, Digestion 31, 120−127.
  147. Rydel, T. J., Ravichandran, K. G., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., and Fenton, J. W., II (1990) The structure of a complex of recombinant hirudin and human α-thrombin, Science 249 , 277−280. · DOI · Paper page
  148. Matthews D. A., 1989, Adv. Enzyme Regul., 29, 60, 10.1016/0065-2571(89)90093-9 · doi:10.1016/0065-2571(89)90093-9
  149. Toyoda N., 1997, Endocrinology 138, 213−219.
  150. Lookene A., 1994, Eur. J. Biochem., 222, 10.1111/j.1432-1033.1994.tb18878.x · DOI
  151. Fitzpatrick P. F., 1991, Biochemistry 30, 3658−3662.
  152. Skarzynski T., 1996, Structure 4, 1465−1474.
  153. Johnston J. O., 1998, Crit. Rev. Biochem. Mol. Biol., 33
  154. Pearson M. A., 1997, Biochemistry 36, 8164−8172.
  155. Rost S., 2004, Nature 427, 537−541.
  156. Cha S., 1975, Biochem. Pharmacol. 24, 2187−2197.
  157. Singh V., 2005, J. Biol. Chem. (in press).
  158. Abbreviations FDA, Food and Drug Administration

Cited by

See all 248

Metadata

Authors
Robertson, J. G.
Venue
Biochemistry
Published
2005-03-22
Volume
44
Issue
15
Pages
5561-5571
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2004519217
Cited by
248
References
1
FWCI
5.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.